Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Genes & Development

• Publication date

  1997-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/GAD.11.24.3341PMID 9407027PMCID PMC316818
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte Growth Factor Promotes Motor Neuron Survival and Synergizes with Ciliary Neurotrophic Factor*

  1997cited by this paper
• Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons.

  1997cited by this paper
• Role of neurotrophic factors in neuronal development.

  1996cited by this paper
• Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development.

  1996cited by this paper
• Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons.

  1996influential reference
• Lack of neurotrophin-3 results in death of spinal sensory neurons and premature differentiation of their precursors.

  1996cited by this paper
• Synchronous Onset of NGF and TrkA Survival Dependence in Developing Dorsal Root Ganglia

  1996cited by this paper
• Specific Uncoupling of GRB2 from the Met Receptor

  1996cited by this paper
• Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis.

  1996cited by this paper
• Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis

  1996cited by this paper
• Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis

  1996cited by this paper
• Physiology of the neurotrophins.

  1996cited by this paper
• Pax3 modulates expression of the c-Met receptor during limb muscle development.

  1996cited by this paper
• Neurotrophic survival molecules for motoneurons: an embarrassment of riches.

  1996cited by this paper
• The sensory innervation of the mouse spinal cord may be patterned by differential expression of and differential responsiveness to semaphorins.

  1996cited by this paper
• Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

  1995cited by this paper
• Scatter factor/hepatocyte growth factor is essential for liver development

  1995cited by this paper
• Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

  1995cited by this paper
• Independent mechanisms converge on pain

  1995cited by this paper
• Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells

  1995cited by this paper
• Neurotrophins regulate dendritic growth in developing visual cortex.

  1995influential reference
• Neurotrophic Factors and Their Receptors

  1995cited by this paper
• Trigeminal sensory neurons require extrinsic signals to switch neurotrophin dependence during the early stages of target field innervation.

  1995cited by this paper
• Guidance and induction of branch formation in developing axons by target-derived diffusible factors.

  1995cited by this paper
• Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development.

  1995cited by this paper
• Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion

  1994cited by this paper
• Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene

  1994cited by this paper
• Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons.

  1994cited by this paper
• Expression and functional interaction of hepatocyte growth factor- scatter factor and its receptor c-met in mammalian brain

  1994cited by this paper
• Neurotrophic factors enter the clinic.

  1994cited by this paper
• Neurotrophic factors: two are better than one.

  1994cited by this paper
• Neurotrophic factors and their receptors

  1994cited by this paper
• The role of neurotrophins in the developing nervous system.

  1994cited by this paper
• A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

  1994cited by this paper
• Role of neurotrophins in mouse neuronal development

  1994cited by this paper
• The Splotch mutation interferes with muscle development in the limbs

  1993cited by this paper
• Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

  1993cited by this paper
• Developmental mechanisms that generate precise patterns of neuronal connectivity.

  1993cited by this paper
• Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.

  1991cited by this paper
• Intrinsic differences in the growth rate of early nerve fibres related to target distance

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Muscle nerve branches do not develop in chick wings devoid of muscle.

  1981cited by this paper

• An open-label single-arm phase 1/2a study to evaluate the safety and exploratory efficacy of a VM202 in patients with Charcot-Marie-Tooth disease 1A.

  2026cites this paper
• The extracellular matrix in peripheral nerve repair and regeneration: a narrative review of its role and therapeutic potential

  2025cites this paper
• MET receptor tyrosine kinase promotes the generation of functional synapses in adult cortical circuits

  2024cites this paper
• MET receptor serves as a promising target in melanoma brain metastases

  2024cites this paper
• Therapeutic Effect of Schwann Cell-Like Cells Differentiated from Human Tonsil-Derived Mesenchymal Stem Cells on Diabetic Neuropathy in db/db Mice

  2024cites this paper
• Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding site

  2023cites this paper
• MET receptor activation by stromal cells serves as promising target in melanoma brain metastases

  2023cites this paper
• Reduced HGF/MET Signaling May Contribute to the Synaptic Pathology in an Alzheimer's Disease Mouse Model

  2022cites this paper
• Advanced Gene-Targeting Therapies for Motor Neuron Diseases and Muscular Dystrophies

  2022cites this paper
• Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss

  2021cites this paper
• When the MET receptor kicks in to resist targeted therapies

  2021cites this paper
• Growth Factors as Axon Guidance Molecules: Lessons From in vitro Studies

  2021cites this paper
• Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome

  2021cites this paper
• Hepatocyte growth factor induces pErk and pSTAT3 (Ser 727) to promote mitochondrial activity and neurite outgrowth in primary dorsal root ganglion cultures

  2021cites this paper
• Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor

  2021cites this paper
• Hepatocyte growth factor is necessary for efficient outgrowth of injured peripheral axons in in vitro culture system and in vivo nerve crush mouse model

  2021cites this paper
• HGF and MET: From Brain Development to Neurological Disorders

  2021cites this paper
• Identification of secreted factors in dental pulp cell-conditioned medium optimized for neuronal growth.

  2021cites this paper
• Familiar growth factors have diverse roles in neural network assembly.

  2021cites this paper
• A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation

  2020cites this paper
• Efficacy of nonviral gene transfer of human hepatocyte growth factor (HGF) against ischemic-reperfusion nerve injury in rats

  2020cites this paper
• Systematic analysis of NLMP suggests nuclear localization of RTK/MET kinases resemble cancer cell clearance

  2019cites this paper
• Development of Enteric Neurons and Muscularis Macrophages

  2019cites this paper
• Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway

  2019cites this paper
• Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase

  2019cites this paper
• Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models

  2019cites this paper
• Intramuscular delivery of HGF-expressing recombinant AAV improves muscle integrity and alleviates neurological symptoms in the nerve crush and SOD1-G93A transgenic mouse models.

  2019cites this paper
• Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism

  2019cites this paper
• Beyond Trophic Factors: Exploiting the Intrinsic Regenerative Properties of Adult Neurons

  2019cites this paper
• Targeting the Hepatocyte Growth Factor Receptor to Overcome Resistance to Targeted Therapies

  2019cites this paper
• Development of Microplatforms to Mimic the In Vivo Architecture of CNS and PNS Physiology and Their Diseases

  2018cites this paper
• Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model

  2018cites this paper
• Placental and Fetal Effects of Onartuzumab, a Met/HGF Signaling Antagonist, When Administered to Pregnant Cynomolgus Monkeys

  2018cites this paper
• [MET exon 14 splicing sites mutations: A new therapeutic opportunity in lung cancer].

  2018cites this paper
• COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer

  2018influential citation
• HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis

  2018cites this paper
• Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients

  2018cites this paper
• Hepatocyte Growth Factor (HGF) Promotes Peripheral Nerve Regeneration by Activating Repair Schwann Cells

  2018cites this paper
• HGFR and FGR2: Their Roles in Progression and Metastasis of Esophageal Cancer

  2018cites this paper
• Disproportionately high levels of HGF induce the degradation of the c-met receptor through the proteasomal degradation pathway.

  2018cites this paper
• Anatomic Variations of the Lateral Femoral Cutaneous Nerve: Remnants of Atypical Nerve Growth Pathways Revisited by Intraneural Fascicular Dissection and a Proposed Classification.

  2018cites this paper
• Title Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK 1 and activation of NF-κ B pathway

  2018cites this paper
• The multiple paths towards MET receptor addiction in cancer

  2018cites this paper
• Plasmid-based gene therapy with hepatocyte growth factor stimulates peripheral nerve regeneration after traumatic injury.

  2018cites this paper
• Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene

  2018cites this paper
• Transplantation of human mobilized mononuclear cells improved diabetic neuropathy.

  2018cites this paper
• Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers

  2017cites this paper
• MET: roles in epithelial-mesenchymal transition and cancer stemness.

  2017cites this paper
• Conséquences de la dérégulation de MET sur le phénotype des cancers bronchiques non à petites cellules EGFR mutés devenus résistant aux inhibiteurs de tyrosine kinase d’EGFR

  2017cites this paper
• Neurobiology of Autism Spectrum Disorders

  2017cites this paper
• MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering

  2017cites this paper
• Semaphorin 4C Plexin-B2 signaling in peripheral sensory neurons is pronociceptive in a model of inflammatory pain

  2017cites this paper
• Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.

  2017cites this paper
• A phosphokinome‐based screen uncovers new drug synergies for cancer driven by liver‐specific gain of nononcogenic receptor tyrosine kinases

  2017cites this paper
• The Met tyrosine kinase receptor as a therapeutic target and a potential cancer stem cell factor responsible for therapy resistance (Review).

  2017cites this paper
• Instructions for use Title Demonstration of the hepatocyte growth factor signaling pathway in the in vitro neuritogenic activity ofchondroitin sulfate from ray fish cartilage

  2017cites this paper
• MET in Lung Cancer: Biomarker Selection Based on Scientific Rationale

  2017cites this paper
• Potential skin involvement in ALS: revisiting Charcot’s observation – a review of skin abnormalities in ALS

  2017cites this paper
• Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma

  2016cites this paper
• Molecular mechanisms of phrenic nerve outgrowth and innervation of the diaphragm

  2016cites this paper
• Signaling by MET

  2016cites this paper
• High-MET status in non-small cell lung tumors correlates with receptor phosphorylation but not with the serum level of soluble form.

  2016cites this paper
• Perspective on a Modified Developmental and Reproductive Toxicity Testing Strategy for Cancer Immunotherapy

  2016cites this paper
• Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach.

  2016cites this paper
• Necrosis- and apoptosis-related Met cleavages have divergent functional consequences

  2015cites this paper
• Modulation of p53 and met expression by Krüppel‐like factor 8 regulates zebrafish cerebellar development

  2015cites this paper
• Induction of insulin‐producing cells from umbilical cord blood‐derived stromal cells by activation of the c‐Met/HGF axis

  2015cites this paper
• Biology of MET: a double life between normal tissue repair and tumor progression.

  2015cites this paper
• Promise and challenges on the horizon of MET-targeted cancer therapeutics.

  2015cites this paper
• Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis

  2015cites this paper
• The autism associated MET receptor tyrosine kinase engages early neuronal growth mechanism and controls glutamatergic circuits development in the forebrain

  2015cites this paper
• Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy

  2015cites this paper
• Conséquences de l'hypoxie sur la régulation de la signalisation HGF/SF-MET

  2015cites this paper
• Hepatocyte Growth Factor and MET Support Mouse Enteric Nervous System Development, the Peristaltic Response, and Intestinal Epithelial Proliferation in Response to Injury

  2015cites this paper
• The apoptotic perspective of autism

  2014cites this paper
• MET and Small-Cell Lung Cancer

  2014cites this paper
• Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors

  2014cites this paper
• Role of Nerve Fibres in Endometriosis

  2014cites this paper
• Effets des clivages du récepteur tyrosine kinase Met par les calpaïnes sur la motilité et la mort cellulaire

  2014cites this paper
• Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress.

  2014cites this paper
• Resistance to targeted cancer drugs through hepatocyte growth factor signaling

  2014cites this paper
• Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling

  2014cites this paper
• Hepatocyte Growth Factor Gene Mutation in Human Colorectal Cancer:Causes and Consequences

  2014cites this paper
• MET Receptor Tyrosine Kinase Controls Dendritic Complexity, Spine Morphogenesis, and Glutamatergic Synapse Maturation in the Hippocampus

  2014cites this paper
• Plasticity versus specificity in RTK signalling modalities for distinct biological outcomes in motor neurons

  2014influential citation
• Molecular and cell biological effects of 3,5,3'-triiodothyronine on progenitor cells of the enteric nervous system in vitro.

  2013cites this paper
• Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

  2013cites this paper
• MET receptor tyrosine kinase as an autism genetic risk factor.

  2013cites this paper
• Met signaling in cardiomyocytes is required for normal cardiac function in adult mice.

  2013cites this paper
• Combined Drug Action of 2-Phenylimidazo[2,1-b]Benzothiazole Derivatives on Cancer Cells According to Their Oncogenic Molecular Signatures

  2012cites this paper
• Mice with Impaired Met Tyrosine Kinase Signaling Demonstrate Characteristics Relevant to Autism

  2012cites this paper
• Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.

  2012cites this paper
• Shedding‐Generated Met Receptor Fragments can be Routed to Either the Proteasomal or the Lysosomal Degradation Pathway

  2012cites this paper
• Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells

  2012cites this paper
• Serum Ghrelin Levels and the Effects of Antidepressants in Major Depressive Disorder and Panic Disorder

  2012cites this paper
• Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

  2012cites this paper
• 'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells.

  2012cites this paper
• Met degradation: more than one stone to shoot a receptor down

  2012cites this paper
• HGF (hepatocyte growth factor (hepapoietin A; scatter factor))

  2012cites this paper
• Identification of new aminoacid amides containing the imidazo[2,1-b]benzothiazol-2-ylphenyl moiety as inhibitors of tumorigenesis by oncogenic Met signaling.

  2012cites this paper